Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Summarecon Agung Tbk. (SMRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Summarecon Agung Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Summarecon Agung Tbk. trades at Rp290 (market cap 4.79T, 8.87M 24h volume). The key difference: Summarecon Agung Tbk. is far larger — about 15.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Summarecon Agung Tbk. is more actively traded (8.87M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | SMRA | |
|---|---|---|
Market Cap | 310.75B | 4.79T |
Volume | 963.6K | 8.87M |
Lot | 9.64K | 88.74K |
Turnover | 217.67M | 2.58B |
Average Price | 225.89 | 291.2 |
Value | 217.67M | 2.58B |
Indicative Equilibrium Price | 226 | 290 |
Indicative Equilibrium Volume | 1K | 866 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Summarecon Agung Tbk.
PT Summarecon Agung Tbk (the Company) was established within the framework of the Domestic Capital Investment Law based on notarial deed No. 308 dated November 26, 1975 of Ridwan Suselo, S.H. PT. Summarecon Agung Tbk is one of the nation`s leading township developers. Entering its twenty-forth year, the original 10-hectare landbank it started with has turned into a vibrant, 500 hectare township in North Jakarta where commercial vivacity peacefully coexists with its houses numbering in the tens of thousands.
Read more on SMRA →
